Lilly plans $400M manufacturing investment
Eli Lilly and Co. has announced a manufacturing expansion in Indianapolis that will add 100 new high-skilled jobs to its operations. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 20, 2019 Category: Pharmaceuticals Source Type: news
How tech plays a critical role in meeting upcoming DSCSA deadlines
With less than a month to go until these new regulations take effect, even the most prepared companies will encounter stark realities. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 20, 2019 Category: Pharmaceuticals Source Type: news
Pfizer nabs FDA approval for Humira biosim
Abrilada is the fifth Humira biosimilar approved in the U.S. and will join generics from Mylan, Samsung Bioepis and Sandoz when AbbVie ' s blockbuster has its patent expire in 2023. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 19, 2019 Category: Pharmaceuticals Source Type: news
Roche buys biotech Promedior in $1.39 billion deal
The Swiss drugmaker will pay $390 million upfront for the privately held biotechnology company specializing in the development of targeted medicines to treat fibrosis. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 19, 2019 Category: Pharmaceuticals Source Type: news
Amgen announces plan to axe 172 jobs
Facing stiffening biosimilar and generics competition, Amgen said it has to cut 172 jobs later this year. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 19, 2019 Category: Pharmaceuticals Source Type: news
Infographic — Data management study finds pharma is not capitalizing on technology
Survey finds that while pharma understands the value of process data, the industry is still hesitating to adopt new data management systems (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 19, 2019 Category: Pharmaceuticals Source Type: news
Supreme Court rejects Shkreli ’s attempt to get out of jail
The U.S. Supreme Court has turned down an appeal attempt by Martin Shkreli this week. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 19, 2019 Category: Pharmaceuticals Source Type: news
NHS faces critical drug shortages
England ' s National Health Service is running short of dozens of lifesaving medicines including treatments for cancer, heart conditions and epilepsy, according to an internal document circulated to doctors. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 18, 2019 Category: Pharmaceuticals Source Type: news
Novartis gets FDA ok for sickle-cell drug
Novartis announced it won U.S. FDA approval for its experimental sickle cell disease drug, Adakveo. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 17, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 11/15/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 15, 2019 Category: Pharmaceuticals Source Type: news
Shionogi antibiotic gets FDA ok with mortality warning
Japan ' s Shionogi announced the U.S. FDA has approved its new antibiotic, Fetroja, for the treatment of complicated urinary tract infections. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 15, 2019 Category: Pharmaceuticals Source Type: news
Teva to resume production of child cancer drug as shortage persists
Teva Pharmaceuticals announced that it will resume production of childhood cancer drug vincristine after a recent shortage. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 15, 2019 Category: Pharmaceuticals Source Type: news
The elephant in the biopharma classroom
Biopharma needs to address its workforce training methods (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 14, 2019 Category: Pharmaceuticals Source Type: news
Outbreak of a deadly swine fever could trigger global heparin shortage
Heparin, one of the world ’s most critical heart medications, could soon run in short supply due to an outbreak of African swine fever that’s wiped out nearly a quarter of the world’s pigs. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 13, 2019 Category: Pharmaceuticals Source Type: news
Mylan hit with warning letter for valsartan manufacturing
The FDA sent a Mylan facility in India a warning letting for its manufacturing of APIs related to the widespread recall of blood pressure medications. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 13, 2019 Category: Pharmaceuticals Source Type: news
